Glomerular disease: Addition of immunosuppression to supportive care does not STOP-IgAN
Nature Reviews Nephrology 12, 61 (2016).
doi:10.1038/nrneph.2015.209
Author: Ellen F. Carney
New data from the STOP-IgAN trial suggest that immunosuppressive treatment might not be beneficial in high-risk patients with IgA nephropathy (IgAN) who are receiving supportive care. This finding is in contrast to the results of previous studies that reported a potential benefit of immunosuppression in
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Ellen F. Carney Tags: Research Highlight Source Type: research
More News: Study | Urology & Nephrology